Owner Cypress Bioscience, Inc.

Inventors Kranzler, Jay D.; Rao, Srinivas G.

Agent Shelston IP

Pub. Number AU-B-2003225206

PCT Number PCT/US03/13247

PCT Pub. Number WO2003/090743

Priority 60/464,288 18.04.03 US; 60/375,068 24.04.02 US

Filing date 24 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 14 February 2008

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/5513 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups